USPTO serial 99599095
RIVERCELL
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- ABID, NABEELA
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with RIVERCELL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ryan Van Olst
Ryan Van Olst Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable and recorded software for predicting cellular behavior by collecting, analyzing, and organizing data, analyzing cell behavior and physiology, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; downloadable and recorded computer software using artificial intelligence (AI) for predicting cellular behavior by collecting, analyzing, and organizing data, using machine learning on images and sequencing output, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; downloadable and recorded software for generating data in the fields of cell biology, biotechnology, and drug discovery; downloadable and recorded computer software using artificial intelligence (AI) for generating data in the fields of cell biology, biotechnology, and drug discovery; laboratory equipment, namely, liquid handlers in the nature of laboratory robots, microscopes and incubators | ACTIVE | — |
| 042 | Scientific research and development services in the fields of cell biology, biotechnology, and drug discovery; conducting scientific research in the fields of cell biology, biotechnology, and drug discovery; conducting cell perturbation experiments for scientific research and drug discovery purposes, namely, scientific research and drug discovery services; data generation, curation, and analysis in the nature of scientific research services in the fields of cell biology, biotechnology, and drug discovery; providing temporary use of non-downloadable cloud-based software for predicting cellular behavior by collecting, analyzing, and organizing data, analyzing cell behavior and physiology, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for predicting cellular behavior by collecting, analyzing, and organizing data, using machine learning on images and sequencing output, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; providing temporary use of non-downloadable cloud-based software for generating data in the fields of cell biology, biotechnology, and drug discovery; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for generating data in the fields of cell biology, biotechnology, and drug discovery | ACTIVE | — |
| 045 | Licensing of intellectual property rights in the fields of cell biology, biotechnology, and drug discovery | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Blossom Life Sciences SAS
- Other trademarks owned by Blossom Life Sciences SAS
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named RIVERCELL
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 11, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 16, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 16, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 10, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 20, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 20, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 20, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 20, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 20, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 19, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 19, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 19, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 14, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 14, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 14, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 14, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 21, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 16, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 16, 2026 | NWAP | NEW APPLICATION ENTERED | — |